Back to Search
Start Over
Long‐acting injectable Cabotegravir: How drug concentrations could help guide patient management.
- Source :
-
British Journal of Clinical Pharmacology . Oct2022, Vol. 88 Issue 10, p4384-4386. 3p. - Publication Year :
- 2022
-
Abstract
- With the introduction of long-acting (LA) injectable antiretrovirals, a new paradigm for HIV prevention and treatment is upon us. Long-acting injectable Cabotegravir: How drug concentrations could help guide patient management May impact the applicability of traditional therapeutic drug monitoring, drug concentration monitoring could help solve patient management issues as CAB-LA use becomes widespread and identify patients at the extremes of drug exposure. [Extracted from the article]
- Subjects :
- *HIV infections
*HIV prevention
*TELEMEDICINE
*DRUG accessibility
*RISK perception
Subjects
Details
- Language :
- English
- ISSN :
- 03065251
- Volume :
- 88
- Issue :
- 10
- Database :
- Academic Search Index
- Journal :
- British Journal of Clinical Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 159026291
- Full Text :
- https://doi.org/10.1111/bcp.15410